The conjugation specialists at Advanced Targeting Systems are proud to announce a new addition to the catalog: MonoBiotin-ZAP Cat. #BT-ZAP Researchers now have more freedom in selecting conjugation strategies. Users have taken advantage of the ability to use biotinylated targeting agents with Streptavidin-ZAP (Cat. #IT-27) a chemical conjugate between saporin and streptavidin. Streptavidin-ZAP converts biotinylated […]
Targeting Tools: MonoBiotin-ZAP Read More »
Read the 2009 Newsletters and recent scientific references 2009, issue 1: Selective deletion of CD8+ T cells by saporin-coupled MHC class I tetramers / by Hess PR, Buntzman AS, Murray SL, Young EF, Frelinger JA / featuring Streptavidin-ZAP (Cat. #IT-27), FITC-labeled SAP antibody (Cat. #FL-02) SFN Poster of the Year Targeting Talk: IgM Primary Antibody Assay 2009, issue 2:
Targeting Trends 2009 Newsletter Read More »
Streptavidin-ZAP (Cat. #IT-27) Saporin conjugated to streptavidin is one of the most useful reagents that we have produced at ATS. It has been used in a wide variety of studies both in academic research and pharmaceutical/biotech labs. Workers are able to easily see if their molecule, that is biotinylated, is internalized by the target cells.
Targeting Tools: Streptavidin-ZAP Read More »
Q: I ordered the Streptavidin-ZAP (Cat. #IT-27) and had my antibody biotinylated a couple of months ago. I am ready to begin the first round of experiments to determine the concentration needed for the secondary. How much of the biotinylated antibody should I put to combine with the streptavidin for intravitreal injections? Can you please
Streptavidin-ZAP concentration ratio Read More »
Q: Some suppliers sell their streptavidin conjugates in amounts given as streptavidin equivalents. Is that also the case for your product, Streptavidin-ZAP? What is important to me is to know what the molar concentration of streptavidin conjugate is, and the volume of your preparation. A: The molar concentration of Streptavidin-ZAP (Cat. #IT-27) will depend on
Streptavidin-ZAP concentration Read More »
Wüstemann T, Haberkorn U, Babich J, Mier W (2019) Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy. Med Res Rev 39(1):40-69. doi: 10.1002/med.21508 PMID: 29771460 Summary: Conjugation to the antibody was achieved by reacting the biotinylated humanized antibody to prostate-specific membrane antigen (PMSA) with Streptavidin-ZAP. Binding potency of the conjugate was comparable to
Ariizumi K, Akiyoshi H, Chung JS, Tomiharu M, Cruz Jr PD (2010) Featured Article: Depletion of syndecan-4+ T lymphocytes by saporin-conjugated DC-HIL alleviates T cell-mediated imflammatory disease. Targeting Trends 11(2) Related Products: Streptavidin-ZAP (Cat. #IT-27) Read the featured article in Targeting Trends. See Also: Akiyoshi H et al. Depleting Syndecan-4+ T Lymphocytes Using Toxin-Bearing Dendritic
Hess PR, Buntzman AS, Murray SL, Young EF, Frelinger JA (2009) Featured Article: Selective deletion of CD8+ T cells by saporin-coupled MHC class I tetramers. Targeting Trends 10(1) Related Products: Streptavidin-ZAP (Cat. #IT-27), Saporin Goat Polyclonal, affinity-purified FITC-labeled (Cat. #AB-15APFL) Read the featured article in Targeting Trends. See Also: Hess PR et al. Selective deletion
Su Y, Zhang X, Bidlingmaier S, Behrens CR, Lee NK, Liu B (2020) ALPPL2 is a highly specific and targetable tumor cell surface antigen. Cancer Res 80(20):4552-4564. doi: 10.1158/0008-5472.CAN-20-1418 PMID: 32868383 Objective: To evaluate therapeutic potential of ALPPL2 targeting. Summary: Exquisite tissue specificity and broad tumor type coverage suggest that ALPPL2 could be an excellent
ALPPL2 is a highly specific and targetable tumor cell surface antigen Read More »
Bloch JS, Sequeira JM, Ramírez AS, Quadros EV, Locher KP (2021) Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B12 uptake route. bioRxiv 2021.08.16.456495. doi: 10.1101/2021.08.16.456495 Related Products: Streptavidin-ZAP (Cat. #IT-27)